Mergers & Acquisitions Mergers & Acquisitions

Illumina, EU Commission field hours of judges' questions to conclude long day’s appeal hearing

Illumina and the European Commission spent this afternoon fielding more than three hours of pointed questioning from the panel of judges considering the US biotech giant's appeal of the EU regulator's assertion of jurisdiction to review its buyout of cancer-test pioneer Grail. 
This morning, Illumina told the EU's General Court

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Natalie McNelis

Senior Correspondent


Natalie McNelis covers mergers for MLex in Brussels. Before joining MLex in 2017, she spent 20 years as an international trade and competition lawyer in law firms including Stibbe and WilmerHale. Natalie has a BA in English from Mount Holyoke College, a JD from Harvard Law School and an LLM in EU law from KU Leuven. She is admitted to the bar in New York.

Discover MLex

Stay on top of global regulatory developments

Latest News